A retrospective study of antiemetic therapies to prevent carboplatin-induced nausea and vomiting in lung cancer

被引：0
|
作者：
Uesugi, Akinori [1 ]
Takabe, Erina [1 ]
Hatano, Syota [1 ]
Yoshida, Takashi [1 ]
Kiuchi, Takaaki [1 ]
Kudo, Youichi [1 ]
Kawanobe, Takeshi [2 ]
Kato, Ryoji [1 ]
机构：
[1] JR Tokyo Gen Hosp, Dept Pharm, Tokyo, Japan
[2] JR Tokyo Gen Hosp, Dept Resp Med, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.05.744
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P30-6
引用
收藏
页码：S349 / S349
页数：1
相关论文
共 50 条
  • [21] Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer
    Srivastava, M
    Brito-Dellan, N
    Davis, MP
    Leach, M
    Lagman, R
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2003, 25 (06) : 578 - 582
  • [22] Clinical trial protocol of doublet therapy and olanzapine for carboplatin-induced nausea and vomiting in patients with thoracic cancer: a multicentre phase II trial
    Iihara, Hirotoshi
    Shimokawa, Mototsugu
    Gomyo, Takenobu
    Fujita, Yukiyoshi
    Yoshida, Tsutomu
    Funaguchi, Norihiko
    Minato, Koichi
    Kaito, Daizo
    Osawa, Tomohiro
    Yamada, Momoko
    Hirose, Chiemi
    Suzuki, Akio
    Ohno, Yasushi
    [J]. BMJ OPEN, 2019, 9 (07):
  • [23] Evaluating the antiemetic administration consistency to prevent chemotherapy-induced nausea and vomiting with the standard guidelines: a prospective observational study
    Vazin, Afsaneh
    Eslami, Davood
    Sahebi, Ebrahim
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 1151 - 1157
  • [24] A OPEN-LABEL, MULTICENTER, PHASE II STUDY EVALUATING 5MG OLANZAPINE COMBINED WITH STANDARD ANTIEMETIC TRIPLET THERAPY FOR PREVENTION OF CARBOPLATIN-INDUCED NAUSEA AND VOMITING IN GYNECOLOGIC PATIENTS
    Abe, M.
    Iihara, H.
    Shimokawa, M.
    Hayasaki, Y.
    Fujita, Y.
    Kanuma, T.
    Matsuoka, R.
    Sakurai, M.
    Morishige, K.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 1014 - 1014
  • [25] A retrospective chart review of the antiemetic effectiveness of risperidone in refractory opioid-induced nausea and vomiting in advanced cancer patients
    Okamoto, Yoshiaki
    Tsuneto, Satoru
    Matsuda, Yoichi
    Inoue, Takaya
    Tanimukai, Hitoshi
    Tazumi, Keiko
    Ono, Yumiko
    Kurokawa, Nobuo
    Uejima, Etsuko
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2007, 34 (02) : 217 - 222
  • [26] Efficacy and safety of 5 mg olanzapine for the prevention of carboplatin-induced nausea and vomiting in patients with thoracic malignancies: A prospective multicenter phase II study
    Fujita, Y.
    Iihara, H.
    Shimokawa, M.
    Sakai, C.
    Ikemura, S.
    Hirose, C.
    Kotake, M.
    Funaguchi, N.
    Gomyo, T.
    Imai, H.
    Hakamata, J.
    Kaito, D.
    Minato, K.
    Arai, T.
    Kawazoe, H.
    Suzuki, A.
    Ohno, Y.
    Okura, H.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1175 - S1176
  • [27] Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in lung cancer patients receiving carboplatin-based therapies.
    Weinstein, Cindy
    Jordan, Karin
    Green, Stuart
    Khanani, Saleem A.
    Beckford-Brathwaite, Elizabeth
    Vallejos, Waldimir
    Pong, Annpey
    Noga, Stephen Joseph
    Rapoport, Bernardo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [28] Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelines
    Petra Ch. Feyer
    Ernesto Maranzano
    Alexander Molassiotis
    Rebecca A. Clark-Snow
    Fausto Roila
    David Warr
    Ian Olver
    [J]. Supportive Care in Cancer, 2005, 13 : 122 - 128
  • [29] COMBINATION ANTIEMETIC THERAPY IN CISPLATIN-INDUCED NAUSEA AND VOMITING
    KREBS, HB
    MYERS, MB
    WHEELOCK, JB
    GOPLERUD, DR
    [J]. CANCER, 1985, 55 (11) : 2645 - 2648
  • [30] Antiemetic therapy options for chemotherapy-induced nausea and vomiting in breast cancer patients
    Chan, Vicky T. C.
    Yeo, Winnie
    [J]. BREAST CANCER-TARGETS AND THERAPY, 2011, 3 : 151 - 160
12345